Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The post 7 Problems with Using Borosilicate Glass to Package Drugs appeared first on Pharma Mirror Magazine.

Packaging 52

Packaging Vaccines 52

Pharma Mirror

DECEMBER 12, 2021

The glass used to package, store, and deliver drugs today was created in 1881 — just 16 years after the Civil War ended — and has changed very little since then, and it’s these vials that drug companies, who are creating ever-evolving, more complex drugs, are beholden to use.

Packaging 52

Packaging 52

European Pharmaceutical Review

OCTOBER 3, 2024

The holistic approach to CCS required by Annex 1 encapsulates primary packaging components and the wider supply chain vital to compliance. In this article, we look at how these elements can be integrated into a joined-up approach that provides pharmaceutical companies with the assurance of end-to-end compliance with Annex 1.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Documentation 52

IDStewardship

OCTOBER 14, 2024

In this article an infectious diseases pharmacist discusses 5 examples where challenging antibiotic workflows can be an issue. BCPS, BCIDP Article Posted October 2024, First Released in the October 2024 IDstewardship Newsletter 1. The process is detailed in the package insert here. Authored By: Timothy P. Gauthier, Pharm.D.,

Compounding 130

Compounding Labelling Packaging Hospitals 130

Pharma Marketing Network

DECEMBER 4, 2024

In this article, we’ll explore 10 innovative trends in pharma marketing that can set you up for success in this rapidly evolving landscape. From eco-friendly packaging to socially responsible campaigns, sustainability resonates with today’s consumers. Learn more about compliance tips at Pharma Marketing.

Communication 52

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

OCTOBER 3, 2024

Preparing for the impact of EU GMP Annex 1 on primary packaging Niamh Bissett and Dr Ana Kuschel West Pharmaceutical Services, Inc. Login or create an account to download your copy of our Issue now!

Packaging 59

Packaging Vaccines FDA 59

European Pharmaceutical Review

AUGUST 23, 2022

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.

Dosage 98

Dosage Packaging Pharmaceutical Companies Pharmaceutical Companies 98

STAT

AUGUST 23, 2024

The comments came in response to an article  The Financial Times  that claimed the company is considered changing the location of a $578 million vaccine manufacturing plant from Liverpool to Philadelphia because the new U.K. Labor government is angling to reduce a subsidy program.

Vaccines 99

Vaccines Packaging 99

European Pharmaceutical Review

MAY 2, 2023

Innovation in clinical trials (article): Why R&D innovation holds the key to greater patient impact … The post FDA releases draft guidance for decentralised clinical trials appeared first on European Pharmaceutical Review. This draft guidance builds on recommendations published by the agency in 2020.

FDA 98

FDA Packaging 98

pharmaphorum

JUNE 1, 2022

In this article, Ben Hargreaves looks at how VR headsets are being used to better educate both healthcare professionals and the general public. The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. In reality. VR for real world education.

Vaccines 145

Vaccines Immunization Hospitals Packaging 145

IDStewardship

NOVEMBER 29, 2023

In this article the host of the Let’s Talk Micro Podcast (Luis Plaza Rios) is interviewed about his experience and learning clinical microbiology using podcasting via the Let’s Talk Micro podcast. I had the pleasure to meet Luis in person and after exchanging some emails we were able to compose this article.

Patient Care 246

Patient Care Hospitals Packaging Communication 246

European Pharmaceutical Review

JANUARY 25, 2024

In a survey conducted by The European Consumer Organisation (BEUC) during June and July 2022, in Belgium, Italy, Portugal and Spain, 79 percent of consumers said paper leaflets should be available inside the package even if there is an alternative QR code on it. 11 This requirement directly contradicts what is included in Article 63.

Packaging 98

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies 98

BioPharm

JANUARY 16, 2024

This article describes how to achieve optimal separation of oligonucleotides and related impurities by utilizing a dedicated method development software package based on AQbD.

Packaging 40

Packaging 40

BioPharm

OCTOBER 27, 2024

Compendial testing covers a wide array of materials, subjects, and locations designed to create standards and programs that ensure the quality and safety of approved articles for a geographical location or areas such as USP (For the United States market) or Ph Eur (For European markets).

Packaging 40

Packaging 40

The Thyroid Pharmacist

MARCH 7, 2025

In this article, Ill share nine sneaky thyroid toxins that could be affecting your thyroid health and, more importantly, how you can minimize your exposure and swap for products with cleaner ingredients. When grocery shopping, try to purchase items that are packaged in glass and canned foods that are packaged with BPA-free lining.

Health and Personal Care Stores 60

Health and Personal Care Stores Labelling Immunization Packaging 60

European Pharmaceutical Review

JUNE 5, 2023

Article: NDMA: a recall trigger for the drug development industry … The recent discovery of small-molecule nitrosamine impurities in marketed drugs, starting with N -nitrosodimethylamine (NDMA) in batches of Valsartan in 2018, has led to significant regulatory response, the paper noted. It was observed that 41.4

Packaging 98

Packaging 98

pharmaphorum

FEBRUARY 9, 2021

As pharma marketers, you are always searching for ways to provide accurate information about your product and package it in a myriad of different ways–all while facing many restrictions. Read the full article on health-union.com. . And with nearly 1.1 The post 5 Ways to Make Your Pharma Marketing More Personal appeared first on.

Packaging 52

Packaging 52

pharmaphorum

MARCH 16, 2022

Part 1 of this article discussed the massive disruptions to medical events caused by the COVID-19 pandemic and how attendees’ preferences have shifted as things have shaken out. Moreover, no attendee data was available for physical symposia, whereas all virtual symposia packages provided full attendee metrics analyses.

Communication 98

Communication Packaging 98

pharmaphorum

MAY 27, 2022

You can read part one of this article here. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines. This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials.

Packaging 80

Packaging Generic Medicine Communication Hospitals 80

pharmaphorum

JANUARY 18, 2022

Primary Packaging material designers. Secondary packagers. POST CONFERENCE WORKSHOP A: EU MDR 2017/745 Article 117 Requirements. Overview of the workshop: The workshop is aimed to provide an introduction to the key elements of the Medical Device Regulation that Companies affected by article 117 need to consider.

Packaging 52

Packaging FDA Documentation Vaccines 52

ISPE

MARCH 7, 2023

This article reviews two case studies that cover sustainable pack types and extension of shelf life. Case Study One: Packaging Materials The first case study looks at developing more sustainable packaging materials and reducing the size of packaging materials. Let’s use the example of the packaging for medicines.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

European Pharmaceutical Review

FEBRUARY 7, 2023

of the MDR and Article 110.4 In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR. of the IVDR for medical devices and in vitro diagnostic medical devices (IVDs).

Packaging 117

Packaging 117

pharmaphorum

NOVEMBER 11, 2022

Instead, the evidence package must translate this into clear clinical outcomes. ACCESS THE FULL ARTICLE HERE. Many therapies will be first in class with novel modes of action. However, for payers, as well as regulators, healthcare professionals, and patients, a new mode of action is not a value driver.

Packaging 52

Packaging 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

These include the multiprotocol nRF52 and nRF53 series systems-on-chip (SoCs) and the cellular nRF91 Series IoT systems-in-package (SiPs). This article was originally published in Verdict.co.uk. Also, the nRF7002 can be utilized with non-Nordic host devices.

Packaging 52

Packaging 52

The Honest Apothecary

MAY 7, 2023

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. All article shared will be free to read and not locked behind an annoying paywall. .” ” PATCH. LĒF FARMS SALAD GREENS RECALL So much for eating healthy! “lēf Farms of Loudon, N.H.

Packaging 52

Packaging Hospitals FDA 52

European Pharmaceutical Review

DECEMBER 13, 2022

Tamper‑evident packaging is also recommended to prevent adulteration or contamination of the excipient. This article first appeared in European Pharmaceutical Review Issue 6 2022. For example, manufacturers must take responsibility to verify the authenticity of the certificate of analysis (CoA) and the data contained within it.

Compounding 105

Compounding FDA Packaging 105

Pharmaceutical Technology

MAY 26, 2023

PWC predicts deal volumes to resemble prior years with the effect of the US Inflation Reduction Act on pricing better understood and less uncertainty surrounding business conditions, according to an article entitled Pharmaceutical & Life Sciences: US Deals 2023 Outlook published on the company’s website.

Packaging 52

Packaging 52

The Checkup by Singlecare

MARCH 10, 2025

In this article, well take a closer look at semaglutide, its costs, and alternatives that may be offered. Learn more from our article on how to get Wegovy covered by insurance. The list price of brand-name forms of semaglutide ranges from $998$1,349 per package, typically a months supply, depending on the dosage prescribed.

Compounding 52

Compounding Insurance Insurance Coverage FDA 52

European Pharmaceutical Review

APRIL 21, 2023

The leaked draft of the European pharmaceutical package is promising on this point as it states that marketing authorisation may be refused if the ERA is not completed or risk mitigation measures are insufficient, and that an ERA programme should be set up for medicines that were authorised before the introduction of the ERA.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Packaging 98

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. That’s what we want to inject into Novo Nordisk.”. Collaborating to prevent diabetes.

Packaging 111

Packaging Communication 111

ISPE

MAY 11, 2023

This article provides insight into process maps and data flows in the biopharma industry using the Reference Architecture Model Industry 4.0 The concepts introduced here will be topics for future articles. In the fourth and last step, the defined work packages are executed. The four-step approach is introduced as a methodology.

Packaging 52

Packaging Documentation Communication Data Entry 52

Aureus Medical Group

OCTOBER 19, 2022

Aureus Medical Group travelers are covered from day one with a comprehensive perks and benefits package that includes: Low-cost, day-one health, vision, and dental. Every agency is different, so discussing your plan’s specifics with your recruiter is best. Unlimited loyalty and referral bonuses. 401k with company match. Updated Oct.

Packaging 98

Packaging Communication Insurance Immunization 98

Pharma Marketing Network

MARCH 25, 2023

This includes everything from the company’s website and social media presence to packaging and advertising. ” Entrepreneur, www.entrepreneur.com/article/314384. All communications, both internal and external, should reflect the brand’s values and personality. References: 1. ” Communiqué, communique.us/creating-strong-brand-identity-pharmaceutical-industry/.

Packaging 52

Packaging Communication 52

The FDA Law Blog

JANUARY 3, 2024

Specifically, CVM ensures that animal drugs are safe and effective, properly made, and adequately labeled and packaged; food-producing animals only take drugs that would be safe for humans to consume; pet foods and additives are safe; and educates the public, monitors the market, and encourages development of new animal health products.

FDA 59

FDA Packaging Labelling Vaccines 59

Pharmaceutical Technology

OCTOBER 23, 2022

The present article is applicable to solid medical devices but not fabrics, drapes, contact lenses or some other particular devices such as dialysis blood flow components. The main drawback of using EO as a sterilization agent is that it can leave toxic residues on the articles being processed. and 2.56mg respectively. Background.

Packaging 40

Packaging 40

European Pharmaceutical Review

FEBRUARY 23, 2023

This article presents an overview of Raman spectroscopy and details some of the developments of interest to the pharmaceutical sector. The potential of Raman for microbiology The current advantages and future potential of Raman spectroscopy as a bacterial identification and enumeration method have been outlined in this article.

Labelling 121

Labelling Packaging 121

Hospital Pharmacy Europe

AUGUST 30, 2024

Based on these findings, we believe that a precaution of use in patients with psychiatric disorders or psychological lability could be added in the semaglutide package insert.’ A version of this article was originally published by our sister publication Pulse.

Packaging 52

Packaging Hospitals 52